Compare Immunovant Inc. Common Stock (IMVT) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Zillow Group Inc Class C — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Zillow Group Inc Class C trades at $29.24 (market cap $6.17B). The key difference: Immunovant Inc. Common Stock and Zillow Group Inc Class C are close in size by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Zillow Group Inc Class C for 39 Days on average.
| IMVT | Z | |
|---|---|---|
Market Cap | $6.62B | $6.17B |
Volume | 1,131,364 | 2,822,928 |
Sector | Health | Media |
52-Week High | $44.96 | $78.04 |
52-Week Low | $17.03 | $27.13 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $5.72B | $6.04B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (Z) trades at $27.28, down 1.52% amid bearish technical signals and a challenging housing market. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability with net income of $23M. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed. Analyst consensus remains mixed with a $60.33 price target representing significant upside potential from current levels.
The stock presents a compelling risk-reward opportunity with strong analyst price targets but faces headwinds from rising mortgage rates and housing market volatility. Zillow's strategic pivot to an integrated transaction platform and AI integration positions it for long-term growth, though near-term performance depends on housing market stabilization and execution of their business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
